duloxetine hydrochloride has been researched along with Reperfusion Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mori, Y; Shimizu, S; Toda, T; Umehara, N; Wakamori, M; Yamamoto, S | 1 |
| Ahn, JH; Bae, EJ; Cho, JH; Kim, YM; Lee, CH; Lee, TK; Park, JH; Shin, MC; Won, MH | 1 |
2 other study(ies) available for duloxetine hydrochloride and Reperfusion Injury
| Article | Year |
|---|---|
Protective Effects of Duloxetine against Cerebral Ischemia-Reperfusion Injury via Transient Receptor Potential Melastatin 2 Inhibition.
Topics: Animals; Antidepressive Agents; Brain Ischemia; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; HEK293 Cells; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuroprotective Agents; Reperfusion Injury; TRPM Cation Channels | 2019 |
Pretreated duloxetine protects hippocampal CA1 pyramidal neurons from ischemia-reperfusion injury through decreases of glial activation and oxidative stress.
Topics: Animals; Brain Ischemia; CA1 Region, Hippocampal; Drug Evaluation, Preclinical; Duloxetine Hydrochloride; Gerbillinae; Male; Neuroglia; Neuroprotective Agents; Oxidative Stress; Pyramidal Cells; Reperfusion Injury; Serotonin and Noradrenaline Reuptake Inhibitors; Superoxide Dismutase-1 | 2016 |